Rezapour Maryam, Moosazadeh Mahmood, Hessami Amirhossein, Khademloo Mohammad, Hosseini Seyed Hamzeh
Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Clin Hypertens. 2022 Nov 15;28(1):33. doi: 10.1186/s40885-022-00216-3.
Insomnia and other sleep disorders can cause an increase in blood pressure, thereby resulting in premature death. Regarding this, the present study was conducted to investigate the relationship between hypertension and parameters related to sleep disorders in Tabari cohort population.
In this cross-sectional study, the data from the enrollment phase of the Tabari cohort study were adopted. Tabari cohort is a part of the PERSIAN (Prospective Epidemiological Research Studies in Iran) cohort study. Data analysis was performed using descriptive and inferential statistics.
Out of 10,255 patients enrolled in the Tabari cohort, 2,281 patients (22.2%) had hypertension. According to the results of univariable logistic regression test, the odds ratio of high blood pressure in patients with insomnia and hypersomnia is 1.22 (95% confidence interval [CI], 1.06-1.40) and 1.22 (95% CI, 1.01-1.47) times higher than normal sleep. This odds ratio was not significant after adjusting the effect of sex, age, body mass index, waist circumference, area residence, high-density lipoprotein cholesterol, triglyceride, and total cholesterol variables with multivariable logistic regression. Frequency of routine hypnotic medication usage (14.6% vs. 5.7%, P < 0.001), involuntary napping (25.3% vs. 19%, P < 0.001), and leg restlessness during sleep (14.8% vs. 11.7%, P < 0.001) was higher in hypertensive individuals than in nonhypertensive cases.
This study showed that sleep disorders prevalence are higher in hypertensive patients than nonhypertensive patients. Also, routine use of hypnotics was significantly higher medication in patients with hypertension compared to that in the nonhypertensive patients.
失眠及其他睡眠障碍会导致血压升高,进而引发过早死亡。鉴于此,本研究旨在调查塔巴里队列人群中高血压与睡眠障碍相关参数之间的关系。
在这项横断面研究中,采用了塔巴里队列研究入组阶段的数据。塔巴里队列是伊朗前瞻性流行病学研究(PERSIAN)队列研究的一部分。数据分析采用描述性和推断性统计方法。
在塔巴里队列纳入的10255例患者中,2281例(22.2%)患有高血压。根据单变量逻辑回归测试结果,失眠和睡眠过多患者患高血压的优势比分别为1.22(95%置信区间[CI],1.06 - 1.40)和1.22(95%CI,1.01 - 1.47),高于正常睡眠者。在对性别、年龄、体重指数、腰围、居住地区、高密度脂蛋白胆固醇、甘油三酯和总胆固醇变量的影响进行多变量逻辑回归调整后,该优势比无统计学意义。高血压患者常规使用催眠药物的频率(14.6%对5.7%,P < 0.001)、非自愿小睡(25.3%对19%,P < 0.001)以及睡眠期间腿部不安的频率(14.8%对11.7%,P < 0.001)均高于非高血压患者。
本研究表明,高血压患者的睡眠障碍患病率高于非高血压患者。此外,与非高血压患者相比,高血压患者常规使用催眠药物的比例显著更高。